DrugPatentWatch Database Preview
Queen Hamamatsu Pet Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for QUEEN HAMAMATSU PET, and what generic and branded alternatives to QUEEN HAMAMATSU PET drugs are available?
QUEEN HAMAMATSU PET has one approved drug.
Drugs and US Patents for Queen Hamamatsu Pet
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Queen Hamamatsu Pet | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203771-001 | Aug 31, 2015 | AP | RX | No | Yes | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.